Tools

LEADER 03360cam 22005417a 4500

001 ssj0000536379;

003 WaSeSS;

005 20220112082112.0;

006 m d ;

007 cr n ;

008 110818s2011 dcua sb 100 0 eng d;

010 a| 2011283290;

020 a| 0309161827;

020 a| 9780309161824;

035 a| (WaSeSS)ssj0000536379;

042 a| lccopycat;

049 a| EREEa| NEHH;

050 00 a| RB155.8b| .I557 2011;

082 00 a| 576.52| 23;

110 2 a| Institute of Medicine (U.S.).b| Roundtable on Translating Genomic-Based Research for Health.=| ^A1010804;

245 10 a| Etablishing precompetitive collaborations to stimulate genomics-driven drug developmenth| [electronic resource] :b| workshop summary /c| Steve Olson and Adam C. Berger, rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine of the National Academies.;

260 a| Washington, D.C. :b| National Academies Press,;

300 a| xv, 74 p. :b| col. ill. ;c| 23 cm.;

504 a| Includes bibliographical references.;

505 0 a| Introduction -- A lesson about precompetitive collaboration -- Requisites for successful precompetitive collaboration -- Frameworks for collaboration -- The use of biospecimens in precompetitive collaborations -- Ethical challenges in the use of biospecimens -- Toward developing a cultural, legal, and behavioral framework for precompetitive collaboration.;

506 a| Available only to authorized users.;

520 a| "Despite the many basic research discoveries in genetics, relatively few gene-based treatments, drugs, or preventative measures have been developed. One way to bridge this gap may be for industry, academia, and government to develop partnerships that share resources while distributing risk. However, intellectual property protections and other barriers can inhibit collaborative efforts. The Institute of Medicine held a workshop on July 22, 2010, to explore these issues and develop solutions."--Publisher's description.;

530 a| Also available online.;

538 a| Mode of access: World Wide Web;

650 0 a| Genomicsz| United States.=| ^A528942;

650 0 a| Human genome.=| ^A510488;

650 0 a| Genomicsx| Moral and ethical aspects.=| ^A528942;

650 0 a| Gene therapyx| Government policyz| United States.=| ^A272727;

650 0 a| Public-private sector cooperationz| United States.=| ^A1006406;

655 0 a| Electronic books.=| ^A491897;

700 1 a| Olson, Steve,d| 1956-=| ^A148058;

700 1 a| Berger, Adam C.=| ^A1036269;

856 40 z| Full text available from Ebook Central - Academic Completeu| https://ebookcentral.proquest.com/lib/eastcarolina/detail.action?docID=3378741;

947 a| (OCoLC)ocn694600791;

949 a| CLICK ON WEB ADDRESSw| ASISh| JOYNER188;

949 a| CLICK ON WEB ADDRESSw| ASISh| HSL77;

949 a| CLICK ON WEB ADDRESSw| ASISh| JMUSIC60;

596 a| 1 3 4;

998 a| 4068773;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 4068773-1001l| JNETm| JOYNERr| Ys| Yt| JNESSBKu| 1/1/2016x| EBOOKz| JERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 4068773-2001l| HSLELECm| HSLr| Ys| Yt| HEBKu| 1/1/2016x| EBOOKz| HERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 4068773-3001l| MNETm| JMUSICr| Ys| Yt| MNESSBKu| 1/1/2016x| EBOOKz| JERESOURCE;

Etablishing precompetitive collaborations to stimulate genomics-driven drug development workshop summary / Steve Olson and Adam C. Berger, rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine of the National Academies.

Author/creator	Institute of Medicine (U.S.).
Other author	Olson, Steve, 1956-
Other author	Berger, Adam C.
Format	Electronic
Publication Info	Washington, D.C. : National Academies Press,
Description	xv, 74 p. : col. ill. ; 23 cm.
Supplemental Content	Full text available from Ebook Central - Academic Complete
Subjects	Genomics--United States. Human genome. Genomics--Moral and ethical aspects. Gene therapy--Government policy. --United States. Public-private sector cooperation--United States.

Contents	Introduction -- A lesson about precompetitive collaboration -- Requisites for successful precompetitive collaboration -- Frameworks for collaboration -- The use of biospecimens in precompetitive collaborations -- Ethical challenges in the use of biospecimens -- Toward developing a cultural, legal, and behavioral framework for precompetitive collaboration.
Abstract	"Despite the many basic research discoveries in genetics, relatively few gene-based treatments, drugs, or preventative measures have been developed. One way to bridge this gap may be for industry, academia, and government to develop partnerships that share resources while distributing risk. However, intellectual property protections and other barriers can inhibit collaborative efforts. The Institute of Medicine held a workshop on July 22, 2010, to explore these issues and develop solutions."--Publisher's description.
Bibliography note	Includes bibliographical references.
Access restriction	Available only to authorized users.
Other forms	Also available online.
Technical details	Mode of access: World Wide Web
Genre/form	Electronic books.
LCCN	2011283290
ISBN	0309161827
ISBN	9780309161824

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Etablishing precompetitive collaborations to stimulate genomics-driven drug development workshop summary / Steve Olson and Adam C. Berger, rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine of the National Academies.

Click here for more information about this title

Availability